Over the past 60 days, the SEC's registration queue produced a number with no precedent in the history of American fund products: 390 new ETFs. Half of them contain derivatives. Not one failed the compliance review. The headlines called it a record. The press releases called it innovation.
I have spent the past month reading the fine print instead of the press releases. My reading is different. This is not a wave of product innovation. It is a coordinated accumulation of one trade, wearing 195 different brand names. The trade is volatility. Every buffer fund, every covered call fund, every leveraged and inverse product in that filing queue is, in one way or another, selling volatility to buy an outcome — an income stream, a downside floor, a daily multiple. Selling volatility is a legitimate strategy with decades of professional history. What has never happened is the retailization of that strategy at this scale, in parallel, into the same underlying indices, inside the same two-month window.
We are in a sideways market. That is the first thing to note about the timing: if chop is for positioning, someone has decided that the position worth taking is a massive, retail-facing short on calm. The second thing to note is the silence of the participants. The products are already approved. The marketing has already begun. The questions that matter — about how these products behave together, in a fast drawdown, with everyone positioned the same way — are not being asked in public.
I watched the silence break the noise of 2021 the same way I am watching this queue. The asset was different. The structure of the narrative — a protective promise, purchased faster than it could be understood — was identical.
Context: The Industry the Fee War Built
To feel the weight of 390, you need the baseline the ETF industry spent twenty years building. The American ETF market holds north of $9 trillion. Its core business is the index fund: cheap, transparent, explainable in thirty seconds. Fees have collapsed to between 0.03% and 0.10%. Three houses — BlackRock, Vanguard, State Street — control roughly 80% of the assets. This is a mature, consolidated, low-margin industry. Growth by replication is dead. Growth by differentiation means finding a fee premium that the fee war cannot touch.
The derivatives ETF is that premium. Structurally, these products do something a traditional ETF never does: they do not merely hold assets; they trade the risks around the assets. Three genres dominate the filing queue. Buffer ETFs — also called defined-outcome funds — cap upside to fund a downside floor over a fixed outcome period, usually six to twelve months. Covered call ETFs write call options against an equity portfolio to generate monthly distributions, sacrificing upside for cash flow. Leveraged and inverse ETFs use swaps and futures to deliver daily multiples of index returns.
Each genre has a legitimate institutional history. What is new is not the strategy. What is new is the distribution. The products are being marketed directly to self-directed retail investors and into retirement accounts through the same broker apps that once gamified stock trading. In 2024, the narrative machinery I had spent a year tracking taught me that language moves before money does — we saw it in the shift away from the old crypto vocabulary, a change in wording that preceded the mid-year rally by weeks. The same machinery is now pointed at options. The ETF was invented to make markets simpler. The derivatives ETF reverses that promise — and charges five to ten times the fee for the reversal.
Core: Anatomy of the Flood
Part One — The Economics
Let me begin with the only number that explains the rush. A standard S&P 500 index ETF charges 0.03% to 0.10% annually. A covered call ETF or buffer ETF charges 0.50% to 1.00%. That is a fivefold to tenfold premium for exposure to the same underlying indices. In a market where the index business is a race to zero, the derivatives ETF is not a product innovation; it is a pricing innovation — a way to charge institutional-grade strategy fees to a retail audience that has never been asked to pay them before.
Issuers are rational. When 390 filings land in 60 days, the margin profile is the most attractive thing in the industry. But the economics that look like a fee premium from the front office look like a cost center from the operations floor. Derivatives ETFs require a different machine than spot ETFs. The fund must mark options and swaps to market in real time, monitor its Greeks — delta, gamma, vega, theta — across strikes and expirations, manage counterparty exposure on OTC positions, track margin calls intraday, and update its intraday indicative value every time the underlying breathes. A traditional ETF needs an administrator to price a book of stocks. A derivatives ETF needs a mini trading desk living inside a fund wrapper.
That capability is not evenly distributed. Large issuers have the systems. The smaller issuers rushing the queue are asking their back offices to become derivatives operations overnight. The gap never shows in the prospectus. It shows on the first day the market moves aggressively and the tracking error widens — and the investor pays for the gap in slippage they will never trace.
Part Two — The Sentiment Layer
Before the mechanics, I should describe the social layer, because that is where the product is actually sold. For the past several weeks I have been running a listening pass over the retail conversation, the same way my team did in 2024, when we tracked a basket of influential accounts and identified the drift in language weeks before the market moved. The drift in the options product space is unmistakable, and it is functioning as a systematic misdescription.
The vocabulary attaching to covered call products is borrowed from fixed income: “yield income,” “cash flow,” “bond replacement.” The vocabulary attaching to buffer products is borrowed from insurance: “protection,” “safety,” “downside guard.” The products are neither bonds nor insurance. The vocabulary is doing the work that disclosure should have done — shaping expectation before the first page of the prospectus is opened. Social platforms amplify the drift; the more a post performs, the more confidently the misdescription spreads. By the time the investor reaches the risk-return diagram, the narrative has already selected which document they will read.
This matters because expectation formation is the one variable these products cannot hedge. A buffer fund's math works on realized returns. The investor's disappointment is built on imagined returns. The gap between the two is the true product being sold.
Part Three — The Protection That Is Not Protection
Now the mechanics. Read the marketing of a buffer ETF: “defined downside protection.” Read the prospectus: the product absorbs the first 15% of a decline over a twelve-month period, in exchange for a cap on upside. Taken honestly, the buffer is a deferral, not protection. If the index falls 20%, the fund loses 5% after the buffer absorbs the first 15. It did exactly what it promised. The investor still lost money.
Now the timing problem: if the drawdown arrives in month eleven, the buffer's remaining life is almost exhausted. A sharp decline near the end of the outcome period locks in a loss the investor cannot wait out, because the option structure resets at expiration, sealing the loss at the new, lower base. The protection was conditional on a calendar the investor does not control.
The covered call family carries an inverse version of the same gap. It sells upside — typically a call struck near the current price — to fund a distribution. In a rising market it systematically underperforms its index; the distribution is a return of liquidity, not necessarily a return of profit. Investors who see “monthly income” and classify the product alongside bond funds are making a category error the market will eventually price. In a falling market, the distribution declines and the capital base erodes simultaneously. The bond analogy fails at the exact moment the investor needs it most.
And the third family, leveraged and inverse, carries a documented mathematical flaw: daily compounding means a 2x product does not return twice the index over any holding period beyond one day. In a sideways market — the market we are in — volatility drag quietly consumes wealth even when the index goes nowhere. This is the regime the current filing wave is deployed into. Sideways chop is precisely the environment in which these products are most likely to disappoint relative to the brochure.
Part Four — The Concentration Disguised as Diversity
Now the piece of the record that genuinely concerns me. In a normal filing cycle, the queue reflects a broad spread of strategies: sectors, themes, geographies, asset classes. The current queue is different. The half built on derivatives is heavily concentrated in a forest of products over the same underlyings — most often the S&P 500 and the Nasdaq-100. But the surface concentration in indices is not the deepest risk. The deepest risk is the concentration in the risk factor itself. Buffer funds sell volatility to buy their floors. Covered call funds sell volatility to fund their distributions. Leveraged products absorb volatility by construction. Across 195 products, the common denominator is precisely the same trade: short volatility.
When a retail investor looks at the fund shelf and sees a colorful landscape of strategies, the diversity is an illusion. They have bought the same risk position at different strike prices, issued by different sponsors, wearing different names. And they have bought it simultaneously. The options market is being asked to absorb a coordinated accumulation of volatility exposure from a product category that did not exist at this scale three years ago.
I keep returning to one scenario — not a 3% blip, but a March-2020-style repricing, a fast, brutal drawdown with liquidity in flight. Every buffer fund approaches its downside threshold at once. Every covered call fund watches its option positions lose value and its distribution machinery seize. Every leveraged fund must rebalance in the worst hours, forcing additional selling into a plunging market. Individually, each product behaves as designed. Collectively, they form a correlated pool of forced flows. The protection becomes the mechanism that accelerates the very move it was sold to cushion.
I have seen this shape before. In 2022, after the collapse of the Terra ecosystem, I spent three weeks alone in the hills of Coorg, replaying the story of the algorithmic stablecoin that promised stability through mathematics. The code was not the failure. The failure was a narrative that assumed everyone would keep believing. Derivatives ETFs are not algorithmic stablecoins — the underlying assets are real. But the pattern is the same: a protective story purchased faster than it can be understood. History does not repeat, but the shape of narratives trending toward their own unravelling is remarkably consistent.
Part Five — Regulatory Backward Mapping
I read regulation backward, from the endpoint. The endpoint of this story is already visible in the room behind the headline. When a regulator approves 390 products in 60 days — a substantial share constructed from options, futures, and swaps — it is not because the regulator has concluded each product is safe. It is because the legal framework issued a standardized permission slip, and issuers learned to fill it out faster than the framework can think.
The approval is not endorsement. The approval is lag. The SEC has approved products faster than its policy machinery can evaluate the systemic meaning of what it has approved. This is the compliance-then-patch cycle, the oldest rhythm in financial regulation. Rule 18f-4, the SEC's 2022 derivatives framework, was itself a patch, written in response to the prior generation of leveraged funds. It formalized limits on derivatives exposure and imposed board-level oversight on funds using options and swaps. The 390-product flood now processed under that very rule is a stress test of the rule's assumptions at scale. If the SEC's monthly approval cadence suddenly drops by a third, the patching has begun.
There are two readings of the new SEC's orientation. One says the market-efficiency bent will keep the window open. The other — the one I weigh more heavily — notes that retail-suitability narratives do not require a hostile regulator to become policy. They require one prominent loss event. The American market already knows this script: a product category that professionals understand, retail buys on a simplified pitch, and regulators restrict after the losses arrive. FINRA's arbitration files hold the previous iterations. The product names change. The shape does not.
Based on my audit experience across multiple regulatory eras, I have learned to treat an approval wave not as a statement of confidence but as a measurement of distance from the next rule. And the compliance cost of the patch is rarely borne by the issuers who profited from the window. It is passed to the investors holding the products when the rule lands.
Part Six — The Users in the Disclosure
And then there are the characters no statistic in the filing queue names. I have been exploring the broker apps through which retail investors buy these products. A covered call ETF appears as “high-yield monthly income,” sitting next to bond funds and dividend stocks. The option mechanics are buried in a document most investors will never download. A buffer ETF appears as “defined downside protection,” which sounds like insurance. The fact that the protection is capped, time-limited, and correlated with every other protection product in the category is not in the interface. It is in the fine print, written in the grammar of derivatives, behind a risk-return diagram most investors will not pause to read.
The demographic pattern is not abstract. These products are flowing into retirement accounts — IRA rollovers, 401(k) allocations — where the investor is older, the horizon shorter, and the capacity to recover from a drawdown smaller. The vocabulary of income and protection maps precisely onto the anxieties of a cohort that watched portfolios fall in 2022 and is looking for a promise that this time, it will not happen again. The products are not malformed. The match between complexity and investor is.
I keep a folder of prospectuses from the current filing wave. Reading them side by side, I am struck by the gap between two documents describing the same product: the prospectus satisfies the legal requirement to disclose; the marketing material satisfies the commercial requirement to persuade. They exist in different realities. Regulation is written for the first document. Investors buy the second.
Contrarian: The Graveyard Is the Opportunity
But here is the counter-intuitive part, and it costs me something to say it: the era of maximum risk in this story has probably already passed. The conventional take — that derivatives ETFs are dangerous for retail investors — is becoming the consensus, and consensus narratives are the least useful trade. The more interesting position is that the enormous risk of the flood is already behind us, and the opportunity sits on the other side of the wreckage.
Consider the economics again from the issuer's side. An ETF needs a survival threshold; the industry whispers around $50 million in assets under management. The queue is long, the pool of retail dollars is finite, and a substantial fraction of these 390 products will never reach sustainability. Some will launch, gather a few million, and drift as zombie funds, bleeding operational costs until quietly liquidated. The most probable outcome of the flood is not a systemic crisis. It is a graveyard — a collection of failed products, a handful of ugly surprises, and a permanently scarred reputation for the category.
That graveyard is where the real opportunity lives. The durable winners of the derivatives ETF era will not be the issuers of the 195 imitative products. They will be the infrastructure the industry is forced to build after the damage: risk analytics platforms capable of measuring concentration across products, RegTech systems automating the disclosure standards the post-event patch will require, and the investor-education layer any responsible distribution channel will be forced to demand. In my 2025 research at the intersection of AI and crypto regulation, I watched the same pattern form: enforcement pressure creates the technical market. The same dynamic is about to enter the derivatives ETF space.
And there is a second blind spot in the conventional narrative. The assumption that the approval wave represents institutional endorsement is wrong. The speed of approval is itself the instability. Every record filing statistic becomes, the day after a retail-loss headline, a measure of regulatory negligence. The current window is the most fragile the industry has ever stood in — precisely because it is the widest.
Takeaway: What to Watch While the Queue Is Quiet
The narrative has shifted from “the ETF democratizes markets” to “the ETF industrializes volatility.” I do not yet know which version writes the next chapter. But I know what to watch.
Watch the monthly approval pace — a 30% slowdown is the sound of the patch being drafted. Watch the net flow data — if buffer and covered call funds start bleeding into plain fixed income at the first hint of rate movement, the category's fragility has confirmed itself. Watch the big three: when BlackRock, Vanguard, or State Street launches a core buffer line, the innovation window closes and the consolidation begins.
The quiet before the drawdown is the loudest signal in markets. For now, the filing queue is orderly, record-breaking, and beautiful. That is exactly when I start listening harder. Because the ETF didn't fail the investor in the last cycle. But the story — that protection can be bought at scale, without correlation, without consequence — has never survived contact with the market.
The question is not whether the math works. The question is whether the narrative holds when it matters most.